NO20055922L - Farmasoytiske anvendbare salter av karboksylsyrderivater - Google Patents

Farmasoytiske anvendbare salter av karboksylsyrderivater

Info

Publication number
NO20055922L
NO20055922L NO20055922A NO20055922A NO20055922L NO 20055922 L NO20055922 L NO 20055922L NO 20055922 A NO20055922 A NO 20055922A NO 20055922 A NO20055922 A NO 20055922A NO 20055922 L NO20055922 L NO 20055922L
Authority
NO
Norway
Prior art keywords
oxoethoxy
phenylethyl
ethoxy
hexyl
phenyl
Prior art date
Application number
NO20055922A
Other languages
English (en)
Norwegian (no)
Inventor
Carl-Johan Aurell
Bengt Ohlsson
Anna Minidis
Erica Stahle
Mikael Ulf Johan Dahlstrom
Eva-Lotte Lindstedt Alstermark
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20055922L publication Critical patent/NO20055922L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20055922A 2003-06-18 2005-12-13 Farmasoytiske anvendbare salter av karboksylsyrderivater NO20055922L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0314129.8A GB0314129D0 (en) 2003-06-18 2003-06-18 Therapeutic agents
PCT/SE2004/000964 WO2004110984A1 (en) 2003-06-18 2004-06-16 Pharmaceutically useful salts of carboxylic acid derivates

Publications (1)

Publication Number Publication Date
NO20055922L true NO20055922L (no) 2006-01-06

Family

ID=27636788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055922A NO20055922L (no) 2003-06-18 2005-12-13 Farmasoytiske anvendbare salter av karboksylsyrderivater

Country Status (23)

Country Link
US (1) US20060142389A1 (es)
EP (1) EP1638922A1 (es)
JP (1) JP3822900B1 (es)
KR (1) KR20060027348A (es)
CN (1) CN1809529A (es)
AR (1) AR044801A1 (es)
AU (1) AU2004247610B2 (es)
BR (1) BRPI0411525A (es)
CA (1) CA2528932A1 (es)
CO (1) CO5650228A2 (es)
GB (1) GB0314129D0 (es)
IL (1) IL172167A0 (es)
IS (1) IS8231A (es)
MX (1) MXPA05013714A (es)
MY (1) MY137277A (es)
NO (1) NO20055922L (es)
RU (1) RU2005138590A (es)
SA (1) SA04250169B1 (es)
TW (1) TW200503677A (es)
UA (1) UA81807C2 (es)
UY (1) UY28375A1 (es)
WO (1) WO2004110984A1 (es)
ZA (1) ZA200510252B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
DK1517883T3 (da) 2002-06-20 2008-05-26 Astrazeneca Ab Ortho-substituerede benzoesyrederivater til behandling af insulinresistens
SE0403072D0 (sv) * 2004-12-16 2004-12-16 Astrazeneca Ab Pharmaceutically useful salts of carboxylic acid derivates
WO2007004957A1 (en) * 2005-07-05 2007-01-11 Astrazeneca Ab Novel crystalline form
AR055073A1 (es) * 2005-07-11 2007-08-01 Astrazeneca Ab Agentes terapeuticos
NO2686520T3 (es) 2011-06-06 2018-03-17
US8865748B2 (en) 2011-06-06 2014-10-21 Akebia Therapeutics Inc. Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NZ714963A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
NZ773901A (en) 2015-04-01 2024-07-26 Akebia Therapeutics Inc Compositions and methods for treating anemia
AU2019265629B2 (en) 2018-05-09 2024-09-12 Akebia Therapeutics, Inc. Process for preparing 2-((5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL351898A1 (en) * 1999-04-06 2003-06-30 Sankyo Co O-substituted derivatives of carboxylic acids
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
WO2004110984A1 (en) 2004-12-23
GB0314129D0 (en) 2003-07-23
TW200503677A (en) 2005-02-01
IS8231A (is) 2006-01-13
AU2004247610B2 (en) 2008-04-17
US20060142389A1 (en) 2006-06-29
EP1638922A1 (en) 2006-03-29
SA04250169A (ar) 2005-12-03
AU2004247610A1 (en) 2004-12-23
SA04250169B1 (ar) 2007-08-07
MXPA05013714A (es) 2006-06-27
IL172167A0 (en) 2009-02-11
ZA200510252B (en) 2006-12-27
KR20060027348A (ko) 2006-03-27
JP3822900B1 (ja) 2006-09-20
CO5650228A2 (es) 2006-06-30
AR044801A1 (es) 2005-10-05
MY137277A (en) 2009-01-30
BRPI0411525A (pt) 2006-08-01
UA81807C2 (uk) 2008-02-11
UY28375A1 (es) 2005-01-31
CN1809529A (zh) 2006-07-26
JP2006527766A (ja) 2006-12-07
RU2005138590A (ru) 2006-07-27
CA2528932A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
NO20055922L (no) Farmasoytiske anvendbare salter av karboksylsyrderivater
ATE540051T1 (de) Age-inhibitoren
RS52716B (en) HYDROBENZAMIDE DERIVATIVES AS HEAT SHOCK PROTEIN INHIBITORS HSP90
RS52214B (en) HDAC INHIBITOR PHARMACEUTICAL FORMULATIONS
RS54445B1 (en) 3,5-DIAMINO-6-CHLORO-N- (N- (4- (4- (2- (HEXYL (2,3,4,5,6-PENTAHYDROXYHEXYL) AMINO) ETHOXY) PHENYL) BUTYL) CARBAMIMIDOIL) PYRAZINE -2-CARBOXAMIDE
NO20055923L (no) Farmasoytisk anvendbare salter av karboksylsyrderivater
RS53503B1 (en) AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR
CY1114681T1 (el) Παραγωγο εστερα του αμινοφωσφορικου οξεος και τροποποιητης του υποδοχεα της 1-φωσφορικης σφιγγοσινης που το περιεχει ως δραστικο συστατικο
RS53292B (en) CRYSTAL FORMS 2-THIAZOLYL-4-HINOLINYL-OXY DERIVATIVES, POWERFUL HCV INHIBITOR
RS54485B1 (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
DE602004024545D1 (de) Indungen
BRPI0509982A8 (pt) cepa isolada de escherichia coli, e, método para produzir um composto
CY1116498T1 (el) Διεργασια για την παρασκευη (r)-(-)-3-(καρβαμοϋλομεθυλ)-5-μεθυλεξανοϊκου οξεος και πρεγκαμπαλινης και συνθεση ενδιαμεσων
NO20073755L (no) Ibandronatpolymorf B
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
EA201170057A1 (ru) Способ получения замещенных 2-аминотиазолонов
EA201071424A1 (ru) Сульфонатные соли 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина
EA201170277A1 (ru) Синтез и составы на основе солей изофосфорамидного иприта и его аналогов
BR112015000966B1 (pt) método para a síntese de n-(fosfonometil)glicina ou um de seus derivados selecionados a partir do grupo que consiste em seus sais, seus ésteres de fosfonato e seus sais de éster de fosfonato
SE0201661D0 (sv) New salts
CY1112979T1 (el) Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου
SE0403072D0 (sv) Pharmaceutically useful salts of carboxylic acid derivates
EA200901085A1 (ru) Производные циклогексиламида арилкарбоновой кислоты

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application